Inventor · disambiguated record
Edgar Davidson Charles, Iii
Also filed as: CHARLES EDGAR D · CHARLES EDGAR DAVIDSON · CHARLES III EDGAR DAVIDSON
1 granted patent·3 pending applications·1 citations·filing 2018–2023
17Inventor score
Files withBRISTOL MYERS SQUIBB CO4
Top patents by PatentIndex Score
4 records- 0169US11642395B2Modified fibroblast growth factor 21 (FGF-21) for use in methods for treating nonalcoholic steatohepatitis (NASH)BRISTOL MYERS SQUIBB CO·Filed 2018·Granted May 9, 2023·1 cites·16 claims
- 0266US2023414717A1Modified fibroblast growth factor 21 (fgf-21) for use in methods for treating nonalcoholic steatohepatitis (nash)BRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 0358US2024216352A1Lpa1 antagonists for treating interstitial lung diseaseBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 0450US2024123031A1Methods of treating liver diseasesBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Edgar Davidson Charles, Iii files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →